The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children.
Dimitrije PavlovicIvana BudicTatjana Jevtovic StoimenovDragana StokanovicVesna G MarjanovicMarija StevicMilan SlavkovicDusica SimicPublished in: Pharmacogenomics and personalized medicine (2020)
Further investigations of UGT1A9, CYP2B6 and CYP2C9 and other genes that participate in propofol metabolism as well as detailed analyses of the general conditions, administered therapies and associated diseases could explain the large interindividual variability of propofol metabolism in children.